Vencanna VenturesVENCF +80.00% Graham Number is $0.02 as of Jan. 2026, which is 94% below its 10-year median of 0.33. The stock has 4 warning signs investors should review. Among 601 Drug Manufacturers companies, Vencanna Ventures ranks better than 99.17% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
As of today (2026-07-07), the stock price of Vencanna Ventures is $0.001. Vencanna Ventures's graham number for the quarter that ended in Jan. 2026 was $0.02. Therefore, Vencanna Ventures's Price to Graham Number ratio for today is 0.05.
The historical rank and industry rank for Vencanna Ventures's Graham Number or its related term are showing as below:
During the past 13 years, the highest Price to Graham Number ratio of Vencanna Ventures was 0.70. The lowest was 0.17. And the median was 0.33.
VENCF's Price-to-Graham-Number is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.52 * Ranked among companies with meaningful Price-to-Graham-Number only.
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Vencanna Ventures (OTCPK:VENCF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Vencanna Ventures's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Jan. 2026 )
=
0.001
/
0.02
=
0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Vencanna Ventures Graham Number Related Terms
Vencanna Ventures Graham Number Historical Data
* Premium members only.
The historical data trend for Vencanna Ventures's Graham Number can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vencanna Ventures Price-to-Graham-Number vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Vencanna Ventures's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vencanna Ventures (VENCF) has a Graham Number of $0.02 as of Jan. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Vencanna Ventures and its competitors. This is 94% below median its historical median of 0.33. Over the past decade, Vencanna Ventures' Graham Number has ranged from 0.17 to 0.70. According to the industry distribution chart, Vencanna Ventures ranks #5 out of 601 companies in the Drug Manufacturers industry, placing it in the top 0.8%.
Is Vencanna Ventures' Graham Number too high?
Vencanna Ventures' current Graham Number of $0.02 is 94% below median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.70. The Drug Manufacturers industry median Graham Number is 1.52. Vencanna Ventures' value of $0.02 is 98.7% below this industry median. Based on the distribution chart, Vencanna Ventures ranks #5 out of 601 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Vencanna Ventures' Graham Number compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #5 out of 601 companies for Graham Number. This places Vencanna Ventures in the top 1% of its industry — outperforming the majority of peers. The industry median Graham Number is 1.52. Vencanna Ventures' value of $0.02 is 98.7% below this benchmark. Historically, Vencanna Ventures' own Graham Number has ranged from 0.17 to 0.70 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 1.52, Vencanna Ventures has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Drug Manufacturers company?
The median Graham Number among Drug Manufacturers companies is 1.52, based on 601 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vencanna Ventures's current Graham Number of $0.02 is 98.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median Graham Number is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current Graham Number is $0.02, which is 94% below median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current Graham Number of $0.02. The current Graham Number is $0.02, which is 94% below median its 10-year median of 0.33 and 98.7% below the Drug Manufacturers industry median of 1.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current Graham Number is $0.02 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VENCF has been successfully added to your 